36 Stocks Moving In Wednesday's Mid-Day Session



  • Nxt-ID, Inc. NXTD shares gained 28.9% to $3.21 after the company said it was awarded U.S. General Services Administration contract to distribute personal emergency response systems to Federal, State and Local government purchasers.
  • Biofrontera Inc. BFRI shares climbed 27.6% to $7.02 after Benchmark initiated coverage on the stock with a Buy rating and announced a $11 price target.
  • CMC Materials, Inc. CCMP surged 25.9% to $183.74 after the company announced it will be acquired by Entegris for $6.5 billion in cash and stock.
  • Insignia Systems, Inc. ISIG surged 21.2% to $20.18.
  • Gemini Therapeutics, Inc. GMTX gained 21% to $2.94 after HC Wainwright & Co initiated coverage on the stock with a Buy rating and a $20 price target.
  • mCloud Technologies Corp. MCLD jumped 17.2% to $4.6405 after the company signed a cloud agreement with Virtual Vision to host AssetCare™ customers in Saudi Arabia.
  • Vir Biotechnology, Inc. VIR gained 15.2% to $53.03 after the company announced new preclinical data demonstrating the impact of the significant antigenic shift of the new SARS-CoV-2 Omicron variant.
  • CN Energy Group. Inc. CNEY surged 11% to $2.73.
  • East Stone Acquisition Corporation ESSC rose 10.1% to $14.86 after declining 26% on Tuesday.
  • Tandem Diabetes Care, Inc. TNDM gained 10.1% to $143.82.
  • Conn's, Inc. CONN gained 9.8% to $19.69. Conn's Board of Directors authorized a repurchase program of $150 million of its outstanding stock.
  • Galera Therapeutics, Inc. GRTX rose 9.2% to $2.9490 after BTIG upgraded the stock from Neutral to Buy and announced a $15 price target. Galera Therapeutics shares jumped around 96% on Tuesday after the company announced the primary endpoint met statistical significance in corrected topline efficacy data of Phase 3 ROMAN trial of avasopasem.
  • East Stone Acquisition Corporation ESSC gained 8.2% to $14.60.
  • Eli Lilly and Company LLY surged 8.2% to $269.90 after the company issued FY21 EPS guidance above analyst estimates.
  • Borr Drilling Limited BORR rose 7.9% to $1.6501 after declining over 4% on Tuesday..
  • Mesoblast Limited MESO rose 7.2% to $4.47. Mesoblast shares dropped around 28% on Tuesday after the company was notified by Novartis that it has chosen to terminate the agreement with Mesoblast prior to closing.
  • SeaChange International, Inc. SEAC gained 4% to $1.5699 after the company reported better-than-expected Q3 results.

Check out these big penny stock gainers and losers


  • Idera Pharmaceuticals, Inc. IDRA shares fell 28.7% to $0.6204 after the company announced tilsotolimod updates. The company said no further enrollment in ILLUMINATE-206 trial is planned at this point.
  • Aspen Group, Inc. ASPU shares fell 27.3% to $1.8966 after the company reported worse-than-expected Q2 results and cut FY22 guidance.
  • REV Group, Inc. REVG dropped 21.7% to $12.47 after the company reported worse-than-expected Q4 EPS and sales results and issued FY22 sales guidance below estimates.
  • Atai Life Sciences N.V. ATAI fell 20.8% to $7.93.
  • Zai Lab Limited ZLAB fell 19.2% to $50.65.
  • Legend Biotech Corporation LEGN shares fell 18% to $39.82 after the company reported an offering of $300 million in ADSs.
  • Cerence Inc. CRNC dropped 18% to $64.00. Cerence’s board promoted Dr. Stefan Ortmanns to Chief Executive Officer and Director.
  • LianBio LIAN fell 15.8% to $8.22. LianBio reported a Q3 loss of $0.63 per share.
  • MIND Technology, Inc. MIND shares fell 14.5% to $1.5201. MIND Technology shares gained 30% on Tuesday after the company reported it entered into a Cooperative Research and Development Agreement with the United States Navy's Naval Surface Warfare Center, Panama City Division.
  • Adagio Therapeutics, Inc. ADGI fell 14.2% to $6.23 after Stifel downgraded the stock from Buy to Hold and lowered the price target from $50 to $9. Adagio Therapeutics shares dipped 79% on Tuesday after the company said based on the in vitro findings related to Omicron, it plans to pause patient recruitment in its Phase 2/3 COVID-19 treatment trial at clinical sites in South Africa.
  • BeiGene, Ltd. BGNE fell 13.5% to $240.84. BeiGene reported authorisation of BRUKINSA (zanubrutinib) from the UK’s MHRA for the treatment of adults with Waldenström’s Macroglobulinemia in Great Britain.
  • Alzamend Neuro, Inc. ALZN fell 13.4% to $2.6687 after jumping 28% on Tuesday.
  • Huadi International Group Co., Ltd. HUDI dropped 12.6% to $28.40.
  • Cooper-Standard Holdings Inc. CPS fell 12.4% to $18.58.
  • I-Mab IMAB fell 12.1% to $43.43. I-Mab received IND approval for Phase 1 clinical trial of bispecific antibody TJ-CD4B in solid tumors in China.
  • Nisun International Enterprise Development Group Co., Ltd NISN fell 11.7% to $3.3181.
  • ABM Industries Incorporated ABM fell 9.9% to $41.42 as the company reported fourth-quarter revenue growth of 14.2% year-over-year to $1.69 billion, comprised of 7.4% organic growth and 6.8% from acquisition.
  • CleanSpark, Inc. CLSK dipped 9.4% to $10.97. Cleanspark posted a Q4 loss of $0.15 per share and named new CFO.
  • Livent Corporation LTHM fell 7% to $23.61. Goldman Sachs downgraded Livent from Neutral to Sell and announced a $23 price target.
Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapIntraday UpdateMarketsMoversTrading IdeasMid-Day MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!